Evidence map›Paper›PMID 19794146›Full record

ArticleAmerican journal of physiology. Cell physiology2009

IFN{gamma} regulates retinal pigment epithelial fluid transport.

Rong Li, Arvydas Maminishkis, Tina Banzon, Qin Wan, Stephen Jalickee, Shan Chen, Sheldon S Miller

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01432847 (Generation of Induced Pluripotent Stem), which is not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01432847 recruitingnot on this mapstarted 2011, after this paper: background citation

Generation of Induced Pluripotent Stem (iPS) Cell Lines From Somatic Cells of Participants With Eye Diseases and From Somatic Cells of Matched Controls

TypeobservationalSponsorNational Eye Institute (NEI)Ran2011Enrolled930ConditionsRetinal Disease, AMD, Retinal Degeneration, Retinitis Pigmentosa
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Interferon-mediated regulation of the neurovascular unit in diabetic retinopathy.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Nanofiber Scaffold-Based Tissue-Engineered Retinal Pigment Epithelium to Treat Degenerative Eye Diseases.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2016
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Developing cellular therapies for retinal degenerative diseases.Investigative ophthalmology & visual science · 2014
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rong LiNIH, Bethesda, MD 20892-2510, USA.
Arvydas Maminishkis
Tina Banzon
Qin Wan
Stephen Jalickee
Shan Chen
Sheldon S Miller
National Institutes of Health · US

Funding

Migration and proliferation of human retinal pigment epitheliumZ01EY000436 · NEI · NATIONAL EYE INSTITUTE · PI MILLER, SHELDON S · 2006 to 2008
$1.0M
Cytokine regulation of RPE physiologyZIAEY000467 · NEI · NATIONAL EYE INSTITUTE · PI MILLER, SHELDON · 2009 to 2010
$356k
Intramural NIH HHS Z01 EY000436
6 · The paper itself

Abstract

The present experiments show that IFNgamma receptors are mainly localized to the basolateral membrane of human retinal pigment epithelium (RPE). Activation of these receptors in primary cultures of human fetal RPE inhibited cell proliferation and migration, decreased RPE mitochondrial membrane potential, altered transepithelial potential and resistance, and significantly increased transepithelial fluid absorption. These effects are mediated through JAK-STAT and p38 MAPK signaling pathways. Second messenger signaling through cAMP-PKA pathway- and interferon regulatory factor-1-dependent production of nitric oxide/cGMP stimulated the CFTR at the basolateral membrane and increased transepithelial fluid absorption. In vivo experiments using a rat model of retinal reattachment showed that IFNgamma applied to the anterior surface of the eye can remove extra fluid deposited in the extracellular or subretinal space between the retinal photoreceptors and RPE. Removal of this extra fluid was blocked by a combination of PKA and JAK-STAT pathway inhibitors injected into the subretinal space. These results demonstrate a protective role for IFNgamma in regulating retinal hydration across the outer blood-retinal barrier in inflammatory disease processes and provide the basis for possible therapeutic interventions.

Indexed as

AbsorptionAdultAnimalsBiological TransportBody FluidsCell MovementCell ProliferationCells, CulturedChoroidCyclic AMPCyclic GMPCystic Fibrosis Transmembrane Conductance RegulatorFetusHumansInterferon-gammaInterferon gamma ReceptorCFTR protein, humanCyclic AMPCyclic GMPCystic Fibrosis Transmembrane Conductance RegulatorInterferon-gammaInterferon gamma ReceptorInterferon Regulatory Factor-1IRF1 protein, humanJanus Kinasesp38 Mitogen-Activated Protein KinasesReceptors, InterferonSTAT Transcription Factors

Identifiers

PMID19794146
PMCPMC2793058
OpenAlexW1966450087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.